AKT1 and neoplasm: A study has found that CHI3L1 could activate various signaling pathways, including protein kinase B (AKT), β-catenin, and nuclear factor kappa B (NF-κB), and increase the number of regulatory T cells, stimulating the tumor microenvironment.25